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Abstract
Background: Nonthermal irreversible electroporation is a minimally invasive surgery technology that employs high and brief
electric fields to ablate undesirable tissues. Nonthermal irreversible electroporation can ablate only cells while preserving intact
functional properties of the extracellular structures. Therefore, nonthermal irreversible electroporation can be used to ablate
tissues safely near large blood vessels, the esophagus, or nerves. This suggests that it could be used for thyroid ablation abutting
the esophagus. This study examines the feasibility of using nonthermal irreversible electroporation for thyroid ablation.
Methods: Rats were used to evaluate the effects of nonthermal irreversible electroporation on the thyroid. The procedure
entails the delivery of high electric field pulses (1-3 kV/cm, 100 microseconds) between 2 surface electrodes bracing the thyroid.
The right lobe was treated with various nonthermal irreversible electroporation pulse sequences, and the left was the control.
After 24 hours of the nonthermal irreversible electroporation treatment, the thyroid was examined with hemotoxylin and eosin
histological analysis. Mathematical models of electric fields and the Joule heating-induced temperature raise in the thyroid were
developed to examine the experimental results. Results: Treatment with nonthermal irreversible electroporation leads to
follicular cells damage, associated with cell swelling, inflammatory cell infiltration, and cell ablation. Nonthermal irreversible
electroporation spares the trachea structure. Unusually high electric fields, for these types of tissue, 3000 V/cm, are needed for
thyroid ablation. The mathematical model suggests that this may be related to the heterogeneous structure of the thyroid-induced
distortion of local electric fields. Moreover, most of the tissue does not experience thermal damage inducing temperature
elevation. However, the heterogeneous structure of the thyroid may cause local hot spots with the potential for local thermal
damage. Conclusion: Nonthermal irreversible electroporation with 3000 V/cm can be used for thyroid ablation. Possible appli-
cations are treatment of hyperthyroidism and thyroid cancer. The highly heterogeneous structure of the thyroid distorts the electric
fields and temperature distribution in the thyroid must be considered when designing treatment protocols for this tissue type.
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Introduction
The thyroid gland is an endocrine gland in the neck made of 2
lobes connected by an isthmus and bracing the larynx. The
function of the thyroid is to produce, store, and secrete the
iodine-based hormones tri-iodothyronine and thyroxine.1 A
cross-section in a normal rat thyroid tissue is shown in Figure
1A. The thyroid has an interesting structure. It is made of
hormone secretory cells surrounding cavities filled with a
colloid. The hormones generated by the secretary cells are
stored in the colloidal cavity. The cavity and the surrounding
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cells complex are known as a follicle.2 The secretory cells
release the hormones into this “cavity” where it is bound by
a glycoprotein and stored as a “colloid.” The follicular cells
continuously generate the hormone, which is stored in the
colloid cavity that grows in time as it incorporates the hor-
mone. To secrete the hormone, the hormone is reabsorbed
from the cavity and then released into the surrounding inter-
stitial spaces.3
Hyperthyroidism is characterized by increased thyroid hor-
mone synthesis and secretion from the thyroid gland. The ele-
vated level of thyroid hormones can result in clinical
manifestations ranging from mild to severe toxicity. Next to
diabetes mellitus and osteoporosis, hyperthyroidism is one of
the most common endocrine disorders4. Excess thyroid hor-
mone affects many different organ systems. Commonly
reported symptoms are palpitations, fatigue, anxiety, disturbed
sleep, weight loss, heat intolerance, sweating, and polydipsia.
Frequent physical findings are tachycardia, tremor of the extre-
mities, and weight loss.5,6 Approximately 3% of women and
0.5% of men will develop Graves’ disease, the most common
cause of persistent hyperthyroidism in adults.7
The 3 common options for treating patients with hyperthyr-
oidism are antithyroid drugs (ATDs), radioactive iodine abla-
tion, and surgery. Antithyroid drugs are a preferred primary
treatment. Antithyroid drugs can control the clinical manifes-
tation and reduce the thyroid hormone level to normal, in most
patients. However, ATDs have side effects and drawbacks.
The medication must be taken for between 12 and 18 months,
which leads to difficulties with compliance.8 Patients experi-
ence a high rate of relapse, between 50% and 55%.9,10 The
incidences of drug side effects, such as agranulocytosis, hepa-
totoxicity, and pruritus, have been estimated to be between
0.1% and 5%.11,12 Radioactive iodine therapy is also a com-
mon treatment, especially in North America.13 Radioactive
iodine therapy is a safe and cost-effective choice. However,
calculating the correct dosage is challenging, with miscalcu-
lations causing the outcome of the procedure to vary from
hyperthyroidism to hypothyroidism. Furthermore, women in
pregnancy, breast-feeding, and planning pregnancy are abso-
lutely restricted from this therapy. Thyroidectomy is the third
way of treating hyperthyroidism. It is recommended for
patients having contraindications of ATDs or radioactive
iodine.14 The most frequent complication of thyroidectomy
is hypocalcaemia due to permanent hypoparathyroidism and
complications from surgery such as permanent recurrent lar-
yngeal nerve injury.15
The goal of this study is to introduce and evaluate the fea-
sibility of using a new minimally invasive surgical technology,
nonthermal irreversible electroporation (NTIRE), for thyroid
tissue ablation. Electroporation is the permeabilization of the
cell membrane with microsecond-long, high electric field
pulses delivered across a cell.16,17 According to the magnitude
of electric fields used, the permeabilization can be transient in a
process known as reversible electroporation or permanent in a
process known as irreversible electroporation (IRE). While
reversible electroporation has become the gold standard for
genetic engineering since first introduced for this purpose in
1982,18 the value of IRE in minimally invasive surgery was
recognized only recently. When delivered in a form that mini-
mizes thermal damage, NTIRE electric pulses affect only the
cell membrane and spare the extracellular matrix and sensitive
structure within and around the treated area.19-22 On the
strength of its ablative selectivity, NTIRE has gained impor-
tance in clinical tissue ablation near sensitive structures such as
near large lumen in the liver23 and in the pancreas.24 Recent
studies have also shown that, unlike thermal ablation such as
with radiofrequency and microwave, NTIRE can be safely used
for tissue ablation near the esophagus, sparing the extracellular
structure of the esophagus and nerves.25-27 Electroporation
involves inserting 2 or more thin needle electrodes to brace the
targeted tissue or inserting one thin bipolar electrode in the
targeted tissue, under ultrasound monitoring, and application
of several microsecond-long electric pulses in a procedure that
usually lasts less than a minute. It can also be done percuta-
neously. The finding that NTIRE can be safely used for tissue
ablation near the esophagus, sparing the extracellular structure
of the esophagus, and nerves25-27 have led us to suggest and
explore in this study the use of NTIRE as a simple technique for
minimally invasive surgical ablation of the thyroid. The use of
NTIRE may have advantages over other thyroid ablation tech-
niques as it can be used repeatedly, since the procedure does
not involve drugs or radioactive isotopes.
Figure 1. (A) H&E staining image of normal rat thyroid tissue. The figure shows the colloid cavity structures (the empty spaces are the colloidal
cavity and the dark dots surrounding the cavity are the cells). (B) Grayscale image depicted in (A). (C) Model in COMSOL software. H&E
indicates hematoxylin and eosin.
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The potential use of NTIRE to treat hyperthyroidism was
discussed earlier. In addition, NTIRE may be useful for treat-
ment of thyroid cancer. Patients usually choose to have an
invasive thyroidectomy (surgical removal of the thyroid).
While the procedure has a high rate of success, if the entire
thyroid is removed (total thyroidectomy), the patient requires
daily treatment with thyroid hormone to replace the thyroid’s
natural function for the rest of their life. However, if only a
portion is removed (partial thyroidectomy), the thyroid may be
able to function normally after surgery.28,29 Focal ablation is of
growing interest in treatment of cancer. During the last 5 years,
NTIRE has been already used for focal therapy to treat thou-
sands of patients with liver cancer,30 pancreas cancer,31 and
prostate cancer.22 This minimally invasive surgery may also
have value for treatment of the hyperthyroidism or thyroid
cancer. The goal of this study is to evaluate the feasibility and
to characterize the use of NTIRE for tissue ablation in the
thyroid of a small animal model.
Materials and Methods
In Vivo Experimental Procedure
Eighteen Sprague-Dawley rats weighing 312+ 71 g were used
in this study. All animals received humane care from properly
trained professionals in compliance with both the Principals of
Laboratory Animal Care and the Guide for the Care and Use
of Laboratory Animals, published by the National Institute of
Health (NIH publication no 85-23, revised 1985).
Animals were anaesthetized with 2 mg/kg meloxicam and
0.05 mg/kg buprenorphine followed by chamber induction with
isoflurane. Bupivacaine (up to 8 mg/kg) was administered sub-
cutaneously along the midline of the abdomen as a local
anesthesia. Anesthesia was administered throughout the proce-
dure with vaporized isoflurane. The depth of anesthesia was
assessed prior to surgery and during the surgery by monitoring
the rats’ reflexes to pressure on their tail and feet. The breathing
rate and the color of the nose and tongue were also monitored
and recorded. The depth of anesthesia was assessed before
surgery and throughout the surgical procedure. After the level
of anesthesia was verified, a midline skin incision is made
along the length of the neck. The underlying tissues and sali-
vary glands are retracted laterally. The thyroid muscle is sepa-
rated from the lobes of the thyroid gland. The thyroid glands
are exposed. Extreme care is taken not to damage the trachea
and laryngeal nerve. Sterile surgical techniques were used
throughout the entire surgery. The thyroid has 2 lobes; there-
fore, using 1 lobe as control excludes bias between individuals.
The right lobe was treated in each animal, and the left lobe was
used as control. After partial mobilization of the thyroid from
adjacent tissue, the right thyroid lobe was gently clamped
between 2 flat parallel 3-mm diameter platinum electrodes
(Harvard Apparatus, Holliston, Massachusetts). The distance
between the 2 plate electrodes was 1 mm and was consistent
for all the animals tested. A sequence of 10 or 30 square pulse
with voltage over distance of 1000 V/cm, 2000 V/cm, or 3000
V/cm, 100-microsecond pulse width, separated by 100 milli-
second, was applied between the electrodes, across the thyroid,
using a high-voltage pulse generator designed for electropora-
tion procedures (ECM 830, Harvard Apparatus). At the end of
the experiment, the skin was closed and sutured. Tissue adhe-
sive and a stapler were applied over the skin sutures. The
animals were given 2 additional doses of buprenorphine
(0.05 mg/kg) and meloxicam (2 mg/kg), spaced out over 8-
hour increments. Symptoms that were monitored included
reduced food intake, fever, hunched posture, lack of grooming
or locomotion, swelling around the incision, facial discharges
around the nose and eye, and diarrhea. We examine the thyroid
via thyroid harvest at 24 hours after treatment. As this is the
first time NTIRE technology was applied in thyroid ablation,
we choose the 24 hours as the end point time to evaluate thyroid
ablation. The choice of this end point was motivated by the
results of our experiments with liver ablation, where we found
that the NTIRE-ablated hepatocytes regenerated within 24
hours.32 Obviously, further studies are needed to explore the
long-term dynamics of physiological events in thyroid tissue
treated with NTIRE. Animals were euthanized by a combina-
tion of an overdose of vaporized isoflurane and a bilateral chest
dissection.
Immunohistochemistry
The thyroid lobes were fixed with 10% neutral-buffered for-
malin and submitted to an independent pathology laboratory
(Histo-Tec Laboratory, Hayward, California). The samples
were embedded in paraffin and sectioned with a microtome
(5-m m thick). All samples were cut vertically to the long axis
of thyroid lobe, in a plane that followed the direction from the
positive to the negative electrode, thereby exposing the treated
thyroid area cross-section. Hematoxylin and eosin (H&E)
staining was used to examine the morphology of the treated
thyroid lobe and the control.
Mathematical Model of Electric Field
Figure 1A shows an H&E staining image of normal rat thyroid
tissue. The thyroid tissue is heterogeneous and consists of col-
loidal structures of various dimensions surrounded by thyroid
cells. This image was used to study the effects of the hetero-
geneity on the electric fields that develop during electropora-
tion. The image was imported into GIMP 2.10 (GNU Image
Manipulation Program, freeware; http://www.gimp.com). The
edges of 15 colloids were extracted to generate a grayscale
image. The colloids were separated for easier segmentation
(Figure 1B). The grayscale image was imported into
MATLAB. The finite elements calculation was performed by
COMSOL Multiphysics (COMSOL, Burlington, Massachu-
setts) with the aid of the MATLAB-coupled LiveLink interface
(Figure 1C). The whole computational domain was modeled as
a 1.1 mm length square. The distance between 2 electrodes was
set to 1 mm as in the experiments (Figure 2). The voltages were
applied to the all lines of left electrode. The right electrode was
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taken to ground (0 V), and the left electrode was given a
positive voltage. The thyroid is a highly heterogeneous tis-
sue and the detailed electric and thermal properties of the
thyroid are not available. Therefore, we used what we con-
sider reasonable assumptions in populating the mathematical
data with properties data. The conductivity of the electrodes
was taken to be that of a metal of 5.998  106 S/m. Since
the colloid is a type of gel, the conductivity of the colloid
was set to that of a pure gel of 0.0529 S/m.33 To better
understand the effects of the electrical properties of the
colloid on the electric field that develops during the elec-
troporation of thyroid tissue, we also performed a para-
metric study using different values for the conductivity of
the colloid (0.001, 0.01, 0.05, 0.1, 0.25, and 0.5 S/cm). The
conductivity of the tissue surrounding the colloid was set to
the average thyroid tissue conductivity of 0.511 S/m34
(https://itis.swiss/virtual-population/tissue-properties/data-
base/dielectric-properties/).
The Electric Currents module in COMSOL was used to
solve computational domain with a free triangle mesh using
the Normal preset values. All external line boundaries were set
as insulators by the following equations:
n  J ¼ 0 ð1Þ
Electric potential V was calculated in the computational
domain by the Laplace equation:
r2V ¼ 0 ð2Þ
The electric current density J distribution can be solved by
the following equation:
r  J ¼ Q ð3Þ
J ¼ sE þ Je ð4Þ
where J is the current density, Q is the electric charge, Je is
the external current.
The electric field E distribution can be calculated by the
following equation:
E ¼ rV ð5Þ
Figure 1C shows the 5 points near the colloidal inclusions
which we used in the analysis of the results. These 5 points
were chosen at random in the region between the colloids.
Mathematical Model of Temperature Distribution
A numerical simulation was performed to estimate the possi-
bility of Joule heating induced thermal damage in the electro-
poration treated tissue. The numerical model simulates the
treatment of a 2-dimensional heterogeneous thyroid tissue. The
geometry analyzed for heat transfer is the heterogeneous
excerpt from Figure 2A, shown in Figure 2B. As with the
calculation of the electric fields, the thermal analysis is ham-
pered by the fact that the thermal properties of the colloid and
the tissue between the colloids in the thyroid are not known.
Therefore, the thermal properties were chosen to be homoge-
neous at the bulk thermal properties’ values of a thyroid. We
assume that thermal properties are affected by heterogeneity
less than electric properties. Obviously, all these assumptions
lead to a first-order evaluation of the thermal history during the
electroporation process, and future studies must try and
develop models with more accurate data. Nevertheless, it will
be shown later that even this highly simplified model also
produces some interesting insight into the thermal characteris-
tics of the process.
The analysis was performed using a thermal numerical
model from Comsol Multiphysics 5.0, as described in the work
of Daniels and Rubinsky35. Specifically, the electrical potential
Figure 2. The finite element mesh used in the simulation. The geometry (B) analyzed for heat transfer is the heterogeneous excerpt from A.
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was calculated from Equations 1 to 5 and the temperature T in
time t from an equation that ignores the effect of blood flow
and therefore also gives an upper limit to the temperature:
rðkrTÞ þ q00 ¼ rc qT
qt
ð6Þ
where k is the thermal conductivity, q00 is the electrical
energy dissipated, c is the heat capacity, and r is the density.
The model assumes that the initial temperature of the thyroid
tissue is 37C. The thermal conductivity, W/(mK), heat capac-
ity, J/(kgK), and density, kg/m3, of the thyroid were taken to
be, 0.52, 3609, and 1050, respectively.
The analysis is complicated by the highly heterogeneous
structure of the thyroid and the complex electric current distri-
bution in the thyroid. The heat due to the electrical energy
dissipation was calculated from the solution to Equations 1-5
using the expression:
q00 ¼ sjrfj2 ð7Þ
To provide the upper limit of the temperature distribution, we
assumed that the electrodes are at 37C, although it is more
likely that they are at room temperature, 20C. The edges of the
heterogeneous slab are assumed adiabatic. Blood flow is also
ignored. The initial temperature of the tissue is also assumed
37C. These choices were made to generate an upper limit esti-
mate for the temperature distribution in the treated thyroid tissue.
Results
Continuous monitoring of the animals indicated that the ani-
mals did not experience any adverse effects from the NTIRE
treatment procedure. As indicated earlier, in this study, we
compared the effects of the number of pulses and electric fields
magnitude between electrodes on the histology of the thyroid,
24 hours after treatment. The parameters were, 10 and 30
pulses with electric fields of 1000 V/cm, 2000 V/cm, and
3000 V/cm; 100 microsecond; and 100-millisecond interval
time (10 pulses per second). Current clinical applications of
NTIRE use a pulse delivery frequency of 1 Hz because of
concern for heart fibrillation. However, in most of our prelim-
inary studies including the first clinical prostate cancer treat-
ment by IRE protocols,22 we use a 100- millisecond delivery
interval time. A main reason for choosing this frequency is that
muscle paralyzing drugs are not used for small animals. We
have found in our early studies that this higher frequency gen-
erates only a mild and single muscle contraction that the animal
can easily bear, without muscle paralyzing drugs. Microscopic
evaluation of the NTIRE-ablated zone was performed using an
H&E assay. We have performed 3 repeats for each experimen-
tal condition, and the results shown here are typical to all the
repeats.
Experimental Results
Figure 3 shows the histology of the H&E stained thyroid
treated with different voltage over distance between the elec-
trodes (from left to right, 1000 V/cm, 2000 V/cm, and 3000 V/
cm) with 10 pulses, top row, and 30 pulses, bottom row. In each
photograph, the left lobe is the treated lobe, and the right lobe is
the control. The extent of follicular damage increases with an
increase in electric field magnitude and an increase in number
of pulses. This will be more evident in Figures 4–6, which show
magnified details. The ablation area for an electric field of 3000
Figure 3. Macroscopic cross-section of the treated thyroid around the esophagus. Cross-section normal to the esophagus. The left side of the
esophagus is the treated lobe, and the right side of the esophagus is the control. The images are shown as a function of electric voltage/distance
between the electrodes and the number of pulses. Complete damage was observed only for 3000 V/cm and the damages are marked.
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V/cm is marked by a dark outline. In that area, most follicular
cells have disappeared, and the normal thyroid follicle structure
has been destroyed. No change was seen in the control lobes in
all samples. Figures 4–6 show magnified details.
Figure 4 shows micrographs of lobes treated with 10 and 30
pulses of voltage/distance 1000 V/cm in comparison with
untreated controls, at higher magnification. After treatment,
some colloid filled with infiltrated cells and nucleus debris are
seen. Some cytoplasmic limits between follicular cells are
barely distinguishable. However, most follicle appear intact.
Figure 5 shows higher magnification micrographs of lobes
treated with 10 and 30 pulses of voltage/distance of 2000 V/cm
Figure 5. Treatment with 2000 V/cm. The panels from left are control (A), 10 pulses treated lobe (B), and 30 pulses treated lobe (C). Thin arrows
(u) pointed to the colloid filled with infiltrated inflammatory cells and nucleus debris. Triangle arrow (") pointed to the follicular cells whose
cytoplasmic limits between the cells were barely distinguishable, some nucleus had disappeared. Thick arrows (˘) pointed to the congestion and
hemorrhagic change in ablation area. The arrow head ( ) pointed to the region of swollen connective tissue. The white arrows (]) pointed to the
ballooned follicular cells. The letter F represented the follicle, inwhich the follicular cells had disappeared, nucleus debris, inflammatory cells spread.
Figure 4. Treatment with voltage/distance of 1000 V/cm. The panels from left are control (A), 10 pulses treated lobe (B), and 30 pulses treated
lobe (C). Thin arrows (u) pointed to the colloid filled with infiltrated inflammatory cells and nucleus debris. Triangle arrow (") pointed to the
follicular cells whose cytoplasmic limits between the cells were barely distinguishable, some nucleus had disappeared.
Figure 6. Treatment with voltage/distance of 3000 V/cm. The panels from left are control (A), 10 pulses treated lobe (B), and 30 pulses treated
lobe (C). Thick arrows (˘) point to the congestion and hemorrhagic change in ablation area. The letter F represents the destroyed follicle, in
which the follicular cells had disappeared, nucleus debris, inflammatory cells spread.
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in comparison with untreated controls. These micrographs show
more nuclei debris and inflammatory cells filled with colloid, in
comparison to the thyroid tissue treated with 1000 V/cm. Conges-
tion andhemorrhagic changes are also seen in the treated areas.The
connective tissue is swollen. Some follicular cells disappeared, and
corresponding follicles have lost their normal structure.
Figure 6 shows the changes in the thyroid tissue following
treatment with 10 and 30 pulses of voltage/distance 3000 V/cm.
The ablation from 3000 V/cm is much more extensive than
from 1000 V/cm or 2000 V/cm. Compared to the effects of
treatment with 1000 V/cm and 2000 V/cm, after treatment with
3000 V/cm, most follicular cells have disappeared. The abla-
tion is particularly large for 30 pulses. A large amount of thyr-
oid follicles have lost their normal structure. Nucleus debris,
inflammatory cells, congestion, and hemorrhagic change are
seen throughout the treated area.
Figure 7 shows the morphology of the trachea in controls
and near the lobe treated with the different protocols in this
study. No difference is seen in the trachea morphology between
the part adjacent to the control side and the parts adjacent to the
NTIRE treated side, for any of the treatment parameters.
Mathematical Analysis of Electric Fields
Figure 8 illustrates the results of the analysis and shows the
electric potential distribution and electric field distribution in
the thyroid tissue for the external voltage/distance of 2000 V/
cm, between electrodes. Each color band represents a specific
voltage range. Figure 8A indicates that the voltage gradient is
not uniform in the direction of the applied electric field. Figure
8B demonstrates that the electric field is significantly distorted
near the colloidal structures. Moreover, the electric field in the
vicinity of the colloid margin is significantly lower than the
voltage over distance value of 2000 V/cm. Obviously, the het-
erogeneity due to the presence of the colloidal structure
severely distorts the electric field distribution, thus influencing
the thyroid ablation by IRE treatment.
Figure 7. Images at the boundary between the trachea and the thyroid. The upper panels represent 10 pulses treatment, from left are control (A1),
1000 V/cm (A2), 2000 V/cm (A3),and 3000 V/cm (A4). The lower panels represent 30 pulses treatment, from left are control (B1), 1000 V/cm
(B2), 2000 V/cm (B3),and 3000 V/cm (B4). Although the follicles were destroyed after the NTIRE treatment, the trachea retains a normal
structure. NTIRE indicates nonthermal irreversible electroporation.
Figure 8. Electric potential distribution (A) and electric field distribution (B) in thyroid tissue. The voltage over distance is 2000 V/cm. The
electrode distance is 1 mm.
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Figure 9A shows the electric current density distribution in
the thyroid tissue and Figure 9B shows the electric current
direction in the thyroid tissue. Because of the relatively low
conductivity of colloid, the current density is also lower inside
the colloid. The electric current density distribution near the
circle of colloid was also not uniform. Figure 9B shows the
electric current direction arrow in the thyroid tissue. Because of
the low conductivity of the colloid relative to the surrounding
tissue, the electric current mainly bypasses the colloid and
flows around the colloid.
For a more precise analysis, we evaluated the electric field
at each of the 5 points marked in Figure 1C for voltage/distance
of 1000 V/cm, 2000 V/cm, and 3000 V/cm. The results are
displayed in Figure 10. It is interesting to notice that at 4 of
the points, the electric field is lower than the respective value of
voltage/distance. However, there is also 1 point at which the
electric field is higher than the voltage/distance value. For
example, the electric field at point 5 is only 903 V/cm, which
is 121.5% lower than excepted value of 2000 V/cm. However,
the electric field at point 1 is 2180 V/cm, which is 9% higher
than the excepted value of 2000 V/cm.
Figure 11 shows the electric field in the thyroid tissue for the
5 different points marked in Figure 1C with increasing conduc-
tivity of colloid, at the voltage/distance of 2000 V/cm. The
Figure 9. Electric current density distribution (A) and electric current direction arrow (B) in thyroid tissue. The voltage over distance is 2000 V/
cm. The electrode distance is 1 mm.
Figure 10. Comparison of the calculated electric field with expected value in homogeneous tissue in the thyroid tissue for 5 different points for
the voltage/distance values of 1000 V/cm (A), 2000 V/cm (B), and 3000 V/cm (C).
Figure 11. Electric field in the thyroid tissue for 5 different points with
increasing conductivity of colloid at the voltage/distance of 2000 V/cm.
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conductivity of thyroid tissue around the colloid was set to be
0.511 S/m. In Figure 10, we show that the electric field at point
1 is higher than the voltage/distance value. Interestingly, with
increasing conductivity of the colloid, the electric field at point
5 becomes gradually lower and close to the value of 2000 V/
cm. However, at the other 4 points, the electric field increases
significantly with increasing conductivity of colloid. When the
conductivity of colloid reaches 0.5 S/m, that is, the tissue
becomes almost homogeneous, the electric field at all points
is close to the value of 2000 V/cm, which is as expected for a
homogeneous tissue.
Figure 12 may explain the partial ablation observed with a
voltage/distance parameter of 2000 V/cm. It shows the area
where the electric field is over the expected value of 2000 V/
cm with increasing conductivity of the colloid. The conductiv-
ity of thyroid tissue around the colloid was set to 0.511 S/m. It
is evident that the area with an electric field close to 2000 V/cm
increases when the conductivity of the colloid approaches that
of the surrounding tissue. In the nominal conditions, the only
half the area around the colloid experiences an electric field of
2000 V/cm. However, when the conductivity of the colloid is
0.5 S/m (close to the conductivity of surrounding thyroid tis-
sue), almost the entire area between the electrodes experiences
an electric field of 2000 V/cm, which is as expected in a homo-
geneous domain. While the mathematical results are obvious,
this study describes a real-life configuration. Of practical clin-
ical importance, the heterogeneous nature of the tissue has a
critical effect on the treatment with NTIRE.
Mathematical Analysis of Temperature Distribution
To provide an upper limit of the thermal effects, we examined
the temperature distribution due to the delivery of a single 1-
millisecond long pulse of 3000 V/cm, which is equivalent to 10
pulses of 100 microseconds. The instantaneous upper limit in
temperature due to the delivery of this pulse is shown in Figure
13B. There is 1 hot spot at which the temperature is 72.6C, but
the majority of the tissue is at temperatures of 50C and lower.
According to the work of Davalos et al,19 a temperature rise
below 50C is not sufficiently high to cause thermal damage.
Figures 13C-E shows that within 1 second, the temperatures
drop below 50C. Since thermal damage is an integration of
temperature and time, it is possible to suggest that in this case
the damage is mostly nonthermal. Obviously, the heterogeneity
of the tissue and the lack of precise thermal data make this
analysis tentative.
To provide a further upper limit of the thermal effects, we
examined the temperature distribution due to the delivery of a
single 3-millisecond long pulse of 3000 V/cm, which is equiv-
alent to 30 pulses of 100 microseconds. The instantaneous
upper limit in temperature due to the delivery of this pulse is
shown in Figure 14B. There is 1 hot spot at which the tempera-
ture is 117C. However, the majority of the tissue is at tem-
peratures lower than 80C, and the colloids are at temperatures
lower than 50C. In the temperature range between 80C and
50C, the thermal damage is an integration of temperature and
Figure 12. The area S where the local electric field is over the electric
field of 2000 V/cm with increasing conductivity of the colloid.
Figure 13. The finite element mesh used in the simulation for thermal analysis (A). The distribution instantaneous (B), 1 (C), 2 (D), and 3 (E)
seconds after the treatment by 10 pulses with 300 V.
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time. Figures 14 C-E shows that within 1 second, the tempera-
tures drop below the thermal damage threshold.19 Again a
temperature rise below 50C is not sufficiently high to cause
thermal damage.19 This analysis suggests that while there may
be selected sites afflicted by thermal damage, the majority of
the treated tissue does not experience thermal damage. Obvi-
ously, the heterogeneity of the tissue and the lack of precise
thermal data make this analysis tentative. Nevertheless, a pos-
sible conclusion is that with 30 pulses of 3000 V/cm, there may
be sites in the tissue that experience thermal damage.
Discussion
The primary goals of this study were to introduce the possible
use of NTIRE for thyroid tissue ablation and determine (1)
whether NTIRE can ablate the thyroid, (2) the effects of vari-
ous electric field magnitude and number of pulses on the extent
of ablation, and (3) the effects of NTIRE treatment of the
thyroid on the adjacent trachea.
It should be noticed that the experimental configuration of
the thyroid braced between 2 parallel plates appears to generate
a 1-dimensional electric field. With this configuration in mind,
it was surprising to observe that unusually high electric fields
were needed for the tissue ablation. The micrographs in Figure
4 show that for thyroid ablation with 1000 V/cm, there are
inflammatory cells and nuclei in the colloid tissue. However,
the damage to the follicles is minimal. Most damage happened
distal to the trachea. It appears that the extent of damage is
similar for a protocol that employed 10 pulses and 30 pulses.
With the voltage increasing to 2000 V/cm, as shown in
Figure 5, some follicular cells are swollen, some follicular cells
disappeared, and the follicle structure began to disintegrate.
The damaged area and the nature of the damage are enhanced
relative to treatment with voltage/distance of 1000 V/cm. As
with the 1000 V/cm protocol, the increase in number of pulses
from 10 to 30 had no effect on the extent of ablation.
Increasing the voltage/distance to 3000 V/cm caused most
follicle structure to collapse. The significance of this is that the
follicles have lost their secretion of thyroid hormone function,
which would have been the goal of the NTIRE treatment. The
damaged area occupied almost the whole treated lobe. An inter-
esting observation from the parametric studies is that the extent
of ablation is strongly related to the magnitude of the electric
field. However, the number of pulses has no noticeable effect.
The image J was used to calculate the thyroid ablation region.
The ablation area by 10 pulses with 3000 V/cm is 3.18+ 0.50
mm2. The ablation area by 30 pulses with 3000 V/cm is 2.75+
1.20 mm2. There is no statistically significance (P ¼ .599)
between 10 and 30 pulses (analysis of variance method).
In addition to tissue ablation by electroporation, there are
several additional mechanisms of damage. They are mechani-
cal damage from the compression of the thyroid, electrolysis
from the electrochemical reaction at the electrodes, and thermal
from Joule heating. Concerning mechanical damage, the
experiments show that there is minimal damage at the low
electric fields. Therefore, this suggests that even if the mechan-
ical pressure had an effect, it is minor relative to the effect of
the electric fields. Electrolysis is a possible additional mechan-
ism of damage and it could occur simultaneously with electro-
poration. This was shown in other studies as well. Saulis et al36
and Turjanski et al37 also found that the electrolysis products
which are inadvertently generated during any type of electro-
poration are detrimental in cells and tissues. Rubinsky et al38
found that the NTIRE electric pulses could induce the electro-
lysis effect which will cause cytotoxic effect for cells during
the tissue electroporation. Stehling et al39 also showed that
combination of electroporation and electrolysis could be able
to ablate the liver tissues. In this study, the NTIRE protocols we
used may also induce electrolysis effect, which may be
involved in the thyroid ablation. The thermal analysis also
provides interesting results. The extreme heterogeneity of the
thyroid suggests that there may be hot spots at which there is
Figure 14. The finite element mesh used in the simulation for thermal analysis (A). The distribution instantaneous (B), 1 (C), 2 (D), and 3 (E)
seconds after the treatment by 30 pulses with 300 V.
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thermal damage, at least for the upper limit of the electropora-
tion parameters of 30 pulses of 3000 V/cm. The analysis sug-
gests that the majority of the treated tissue does not experience
conditions inducive to thermal damage—however, the lack of
precise thermal data of this highly heterogeneous tissue
requires caution with this conclusion.
Since the thyroid is very close to the trachea, the effect of
NTIRE pulses on the trachea is a key consideration in using
NTIRE for the ablation of the thyroid. We monitored the mor-
phology of trachea near the thyroid treated with NTIRE. No
changes were seen to the trachea no matter for any of the
electric fields and pulse numbers in this study, including those
that caused complete ablation of the thyroid.
Several findings emerge from this first feasibility study on
the ability to ablate thyroids with NTIRE. First, it is evident
that NTIRE is capable of complete follicle ablation in the
treated area and the extent of ablation increases with an
increase in electric field; 3000 V/cm is an electric field that
can yield complete ablation in the treated volume. Second, in
all our experiments, the trachea was not affected by NTIRE
applied to the thyroid. This suggests that the technique is safe to
apply near the trachea. This is consistent with the findings of
others. The main reason is that NTIRE affects only the cell
membrane and does not affect the connective tissue. In the
small intestines, we found that the endothelial cells around the
lumen completely regenerate after the NTIRE treatment.40
The study of the NTIRE treatment of the thyroid gave us the
opportunity to examine mathematically the effects of tissue
heterogeneity on the NTIRE treatment in a situation of clinical
importance. Most of the fundamental research on NTIRE was
done in macroscopically homogeneous and isotropic tissues
such as the liver, or the brain or homogeneous and anisotropic
tissues such as the muscle. However, the thyroid represents an
extreme case of a heterogeneous tissue, with a large difference
in electrical conductivity between different macroscopic
regions. At first, we were surprised that 3000 V/cm are needed
to completely ablate the target region. There are several factors
above the electric fields expected to ablate mammalian cells of
the type and dimensions in the thyroid. The mathematical
model shows that if there are low conductivity macroscopic
inclusions in the tissue, the voltage/distance is not a good mea-
sure of the electric fields experienced by the treated tissue and
careful design is needed for such heterogeneous tissues.
Finally, our study is a first order short-term feasibility study
that suggests the potential of the technique. Larger studies and
longer follow-ups will be needed before the technique can be
considered for clinical treatment. As mentioned earlier, this is a
first order study to demonstrate the feasibility and the electrical
parameters needed to ablate thyroid tissue. We choose 24 hours
as the end point time to evaluate thyroid ablation, because of
our past experience from studies with molecular and immuno-
logical responses to NTIRE liver tissue ablation. In those stud-
ies, we found that necroptosis and pyroptosis are the key
mechanisms of cell ablation by NTIRE and these processes
cease at 24 hours; after which hepatocytes begin to regenerate.
Obviously, the thyroid is different from the liver and
substantial more research is needed to understand the dynamics
of NTIRE-induced thyroid ablation. Therefore, when consid-
ering the clinical use of NTIRE for thyroid ablations, practi-
tioners are cautioned that the research in this field is by no
means complete.
Conclusion
The results of this study suggest that NTIRE has the potential to
become a minimally invasive technique for thyroid ablation as
a possible treatment of hyperthyroidism and thyroid cancer.
We found that surprisingly high voltages over distance are
needed for thyroid tissue ablation. The mathematical analysis
suggests that the high voltage over distance needed is due to the
highly heterogeneous structure of the thyroid. A general con-
clusion emerges from this study, when highly heterogeneous
structures are treated with NTIRE, the voltage over distance
parameters of electroporation have a very weak relation to the
actual electric fields that the tissues experience.
We would like to emphasize that the main goal of this article
is to introduce thyroid tissue ablation as a new and possible
valuable application of NTIRE. While the results of the experi-
ments are conclusive, the mathematical models used to analyze
the results are hampered by the lack of reliable data on the
thermal and electrical properties of the highly heterogeneous
thyroid tissue. Therefore, the mathematical analysis makes
what we consider reasonable first order assumptions on the
electrical and thermal properties of the thyroid. However, obvi-
ously, more precise studies with better properties data should
be done in the future.
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